Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer. - Wikidata - wikimedia - TriplyDB

Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer.

Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer.

http://www.wikidata.org/entity/Q39583104

about

Signal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their Crosstalks Biomarkers and Targeted Therapy in Pancreatic Cancer Targeting TGF-β signaling in cancer Tumor stroma as targets for cancer therapy Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy Complexities of TGF-β targeted cancer therapy.The roles of TGFβ in the tumour microenvironment.Process of hepatic metastasis from pancreatic cancer: biology with clinical significance.TGF-ß isoforms in cancer: Immunohistochemical expression and Smad-pathway-activity-analysis in thirteen major tumor types with a critical appraisal of antibody specificity and immunohistochemistry assay validity.Targeting the TGFβ signalling pathway in disease.Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies.Perspectives of TGF-β inhibition in pancreatic and hepatocellular carcinomas.Translational Approaches towards Cancer Gene Therapy: Hurdles and Hopes.TGFβ: A player on multiple fronts in the tumor microenvironment.TGF-β blockade depletes T regulatory cells from metastatic pancreatic tumors in a vaccine dependent manner.Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions.Pharmacological and immunological targeting of tumor mesenchymalization.Targeting TGF-β Signaling for Therapeutic Gain.Transforming growth factor-β: A therapeutic target for cancer.TGF-β in pancreatic cancer initiation and progression: two sides of the same coin Desmoplasia in pancreatic cancer. Can we fight it?Transforming growth factor-β gene silencing using adenovirus expressing TGF-β1 or TGF-β2 shRNA.TGF-β signaling in cancer metastasis.Transforming growth factor-β in stem cells and tissue homeostasis.Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer.Exploring major signaling cascades in melanomagenesis: a rationale route for targetted skin cancer therapy

P2860

Q26752554-2B10951A-97DA-4DDA-BE2D-AB111E104A80 Q26752755-3C285481-0416-4261-8B9C-0FD5EA1244C1 Q27012443-29928674-AFA7-4D84-AC83-BDB360D8126D Q27015980-8FEB1250-4A45-4765-86FC-F90CC05B04C6 Q27021750-18ADB35F-39AB-421A-9CA3-E1691B4E3312 Q27693607-91932965-1A25-4AD7-95D1-14417EBD081C Q33630845-B71E76CE-87BE-4620-B144-231EE54E256D Q35739397-C3FCEB1E-16CE-4763-91DC-BB449F0A3AF0 Q36413606-5D296594-58B5-416F-9E27-67B8D5C5A4AA Q36462348-5BC043AB-855D-402D-A3AD-9EFA92B3F129 Q37617957-F5DCDD09-E9E5-4F3D-9467-84EB9BF1188B Q37649636-53623075-023C-4696-9447-AD32A8523E29 Q38107203-AB6C66EE-B7B9-4137-A490-87461E434A9A Q38241602-91CCF617-B93A-4340-853C-E4FD1C74B56F Q38632049-A3CD4C74-56F7-4E58-8D38-C6EA0C8EB288 Q38841939-FD871B73-913C-49A0-B31F-2552A0E4CF3D Q39029043-2EB1891A-5F9C-4D9D-AEB0-6028EC0EC424 Q39155151-A3E238B9-374A-45B0-9C0B-CA57A6262FC5 Q39346505-482F66BE-5859-4D4A-B8C1-5123D8F7F4C1 Q41272730-72514981-57D5-4FD6-A848-96379A77D3D0 Q41597479-72BB3821-D54A-49BC-8529-FB6182A69712 Q43727484-24FC62D6-DB7E-486E-A97A-C907675A52C9 Q49488316-1FB3F25A-BD7E-4381-BDBE-374BE921AC1A Q50104779-F53E4B1C-E429-4A3B-B2C9-AD6DDB74BA97 Q55312023-91E0AC5E-E367-44B0-A001-0DD408D2A874 Q57044361-BB3A779D-B11F-4ACA-9511-4CC704AA3C76

P2860

Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer.

http://www.wikidata.org/entity/Q39583104

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Transforming growth factor-bet ...... P 12009) in pancreatic cancer.

@en

Transforming growth factor-beta 2 gene silencing with trabedersen

@nl

type

label

Transforming growth factor-bet ...... P 12009) in pancreatic cancer.

@en

Transforming growth factor-beta 2 gene silencing with trabedersen

@nl

prefLabel

Transforming growth factor-bet ...... P 12009) in pancreatic cancer.

@en

Transforming growth factor-beta 2 gene silencing with trabedersen

@nl

P1433

Q39583104-C4FECDB0-9790-4900-83FA-E1EADA3A42E4

P1476

Q39583104-7E28ECFF-62BE-4055-8DE6-8BFECF068378

P2093

Q39583104-21076AEB-7099-43EC-B7D3-3EEC8D512445

Q39583104-33E655B3-D680-44DB-B630-16104A42389B

Q39583104-51620976-E888-4C79-8AC4-7CAB9ECD13A9

Q39583104-6646D33D-9861-478F-91CB-85680394D8FD

Q39583104-81B30B54-D41D-4122-92D9-681B6DAAD22E

Q39583104-DA8F7244-23DC-4B2A-8B17-D9A0518CCB00

Q39583104-F20A74C0-582B-4326-A854-F56ACF517ADE

Q39583104-F29A3D37-F359-436A-B1EA-43BB98E20C50

P2860

Q39583104-01AFE5FC-19DF-4AEB-9462-790F695087DE

Q39583104-0BE74AD5-3CA2-4339-AC69-7E0A5FB80B51

Q39583104-13034FEF-B74F-4CCD-ACBF-EEA11607CDB1

Q39583104-14B9B6D2-410D-4F5E-A2C4-D883D584AC16

Q39583104-14D8DC19-7B2B-41FD-9F9E-B664E5F142C1

Q39583104-157F5643-9516-4BD8-9F5D-47C52F3DD663

Q39583104-23D5E457-4E33-45CF-9B44-725A77CAE50A

Q39583104-3A3B26DD-BE87-41C8-8636-D3A43AB1CE5E

Q39583104-3B9C951A-E59F-4D54-8096-CDA0CBCE07A2

Q39583104-52032A0C-30FF-495C-B863-07FEE28C5449

P304

Q39583104-D223A89A-B5A8-427C-9363-7BE4589D23BC

P31

Q39583104-6EE61C7D-BA87-4F8E-8FEE-F73188B07A93

P356

Q39583104-7CFE4E8F-DB54-4E11-B25D-5F3176FC6E72

P433

Q39583104-85820F15-741F-43E7-A584-4C4B81BDFBD6

P478

Q39583104-BB5A3A96-25F5-45EF-9D38-4E7B785CDB43

P577

Q39583104-B268F71E-A9EE-4F9A-A263-0FF48EBDC45F

P5875

Q39583104-52302FDC-7C37-433B-BCDC-E4DE4E02BFCB

P698

Q39583104-A91056AD-5D2E-4103-B90E-F2F9197F673B

P921

Q39583104-6292634C-3498-4B13-B61A-FF9937A6527C

P356

J.1349-7006.2011.01917.X

P1433

P1476

Transforming growth factor-bet ...... P 12009) in pancreatic cancer.

@en

P2093

Anneliese Schneider

http://www.w3.org/2001/XMLSchema#string

Christian Moser

http://www.w3.org/2001/XMLSchema#string

Edward Kenneth Geissler

http://www.w3.org/2001/XMLSchema#string

Frank Jaschinski

http://www.w3.org/2001/XMLSchema#string

Hans Jürgen Schlitt

http://www.w3.org/2001/XMLSchema#string

Karl-Hermann Schlingensiepen

http://www.w3.org/2001/XMLSchema#string

Marcus Kielmanowicz

http://www.w3.org/2001/XMLSchema#string

Sven Arke Lang

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2008

TGFbeta in Cancer

Cancer statistics, 2009

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

TGF-beta signaling: positive and negative effects on tumorigenesis.

TGF-beta and cancer.

Characterization of oligonucleotide transport into living cells.

TGF-beta-based immunotherapy for cancer: breaching the tumor firewall.

Novel clinical strategies for the treatment of pancreatic carcinoma.

Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival.

P304

1193-1200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1349-7006.2011.01917.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50265817

http://www.w3.org/2001/XMLSchema#string

P698

21366804

http://www.w3.org/2001/XMLSchema#string

P921